NEW Own AMPH? Add It To Your Portfolio Tracker

Every AMPH payout and every new DRIP share, tracked for you — nothing to update by hand.

Add AMPH »

AMPH | NASDAQ

$27.72 $0.79 | 2.93%

TREND SIGNAL: Signal available — unlock to view

|2026-10-22

Next Earnings: Nov 05, 2026

Add to favoritesFavorite

Company Overview:

Market Cap: $0

Trailing PE: 16.4x

FWD PE *: 8.7x

Payout Ratio (TTM): —

52-Week Range: $16.65 - $29.52

* Forward PE is based on street estimates.

10 Year AMPH Performance Metrics:

Total Return (with DRIP): 54.4% (4.44% CAGR)

Total Return (no DRIP): 54.4% (4.44% CAGR)

Share Price: 59.9% (4.80% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $15,443

Total Return $ (with DRIP): $5,443

AMPH Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

AMPH Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Build Custom Charts

AMPH - Chart 1

AMPH - Chart 2

AMPH - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

AMPH Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

AMPH - Revenue

AMPH Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Earnings Per Share (EPS)

AMPH EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Net Income

🔓 See the full chart25% off right now · 7-day free trial

AMPH Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - EBITDA

🔓 See the full chart25% off right now · 7-day free trial

AMPH EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Free Cash Flow

🔓 See the full chart25% off right now · 7-day free trial

AMPH Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Free Cash Flow / Share

🔓 See the full chart25% off right now · 7-day free trial

AMPH Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Operating Income

🔓 See the full chart25% off right now · 7-day free trial

AMPH Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Gross Profit

🔓 See the full chart25% off right now · 7-day free trial

AMPH Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Shares Outstanding

🔓 See the full chart25% off right now · 7-day free trial

AMPH Shares Outstanding CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Share Buybacks

🔓 See the full chart25% off right now · 7-day free trial

AMPH Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Stock-Based Comp

🔓 See the full chart25% off right now · 7-day free trial

AMPH Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Expenses

🔓 See the full chart25% off right now · 7-day free trial

AMPH Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Revenue vs Net Income

🔓 See the full chart25% off right now · 7-day free trial

AMPH - EPS vs FCF / Share

🔓 See the full chart25% off right now · 7-day free trial

AMPH - EPS vs PE Ratio

🔓 See the full chart25% off right now · 7-day free trial

AMPH - FCF vs FCF / Share

🔓 See the full chart25% off right now · 7-day free trial

AMPH - FCF vs Stock Based Comp

🔓 See the full chart25% off right now · 7-day free trial

AMPH - Cash & Debt

🔓 See the full chart25% off right now · 7-day free trial

AMPH - Revenue by Segment

🔓 See the full chart25% off right now · 7-day free trial

AMPH Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Revenue by Region

🔓 See the full chart25% off right now · 7-day free trial

AMPH Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

AMPH - REVENUE: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

AMPH Actual Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - EPS: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

AMPH Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - NET INCOME: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

AMPH Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - EBITDA: Actual + Estimates

🔓 See the full chart25% off right now · 7-day free trial

AMPH Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

AMPH - Net Profit Margin

🔓 See the full chart25% off right now · 7-day free trial

AMPH Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Gross Profit Margin

🔓 See the full chart25% off right now · 7-day free trial

AMPH Gross Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Price to Earnings

🔓 See the full chart25% off right now · 7-day free trial

AMPH Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Price To Sales Ratio

🔓 See the full chart25% off right now · 7-day free trial

AMPH Price To Sales Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Return on Capital Employed

🔓 See the full chart25% off right now · 7-day free trial

AMPH Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

AMPH - Return on Invested Capital

🔓 See the full chart25% off right now · 7-day free trial

AMPH Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Projected Future Returns & Dividends for AMPH

Based on past 10-year performance, here are AMPH growth metrics:

Share price CAGR of +4.33%
Dividend CAGR of +0%

Using AMPH CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	AMPH (DRIP)	AMPH - No DRIP
Current Price	$27.72	$27.72
Start Shares	360.75	360.75
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	360.75	360.75
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$27.72	$27.72
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - AMPH

NOTE: Above numbers are our estimate based on AMPH's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

Company Info

Amphastar Pharmaceuticals, Inc. (AMPH) had its IPO on , and is traded on NASDAQ stock exchange.

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and markets technically challenging generic and proprietary injectable, inhalation, and intranasal products. Amphastar Pharmaceuticals, Inc. also supplies active pharmaceutical ingredient products, including insulin APIs, supporting both its own finished medicines and external customers. Its portfolio includes prescription and over-the-counter treatments used in hospital, urgent care, and retail pharmacy settings, with products addressing areas such as respiratory care, allergic reactions, anticoagulation, opioid overdose reversal, and diagnostic support. The company operates through its Pharmaceutical Products segment and emphasizes complex drug delivery systems, biologics, and biosimilar capabilities. Amphastar Pharmaceuticals, Inc. serves healthcare providers, distributors, and patients across the United States and selected international markets.

AMPH website: https://www.amphastar.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $128.25/yr ($10.69/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Trend Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 44% Lifetime Discount

DCF Model — AMPH

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $27.72

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →